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H I G H L I G H T S
 An oral dose of methamidophos was administered to six volunteers at ADI level.
 The study has quantiﬁed methamidophos in timed urinary collections.
 Methamidophos exhibited a rapid elimination half-life of 1.1 h.
 Mean dose recovery excreted as unchanged methamidophos in urine is low – only 1.1%.
 Short half-life means estimates of exposure likely to be highly variable.
A R T I C L E I N F O
Article history:
Received 31 July 2014
Received in revised form 8 October 2014
Accepted 9 October 2014
Available online 12 October 2014
Keywords:
Methamidophos
Urine
Biological monitoring
Acceptable daily intake
A B S T R A C T
An oral dose of the organophosphate insecticide methamidophos was administered to six volunteers at
the acceptable daily intake (ADI, 0.004 mg/kg).
Urine was collected from the volunteers at timed intervals for 24 h post-exposure. Methamidophos
itself was quantiﬁed in urine using liquid/liquid extraction and LC–MS-MS analysis (detection limit
7 nmol/L/1 mg/L).
Methamidophos exhibited a rapid elimination half-life of 1.1 h, (range 0.4–1.5 h). Mean metabolite
levels found in 24 h total urine collections (normalised for a 70 kg volunteer) were 9.2 nmol/L (range
1.0–19.1). One volunteer was anomalous; excluding this result the range was 6.7–19.1 nmol/L, with a
mean of 10.9 nmol/L. Individual urine samples collected during the ﬁrst 24 h ranged from below the
detection limit (ND) to 237 nmol/L. The mean dose recovery excreted as methamidophos in urine was
1.1% (range 0.04–1.71%).
Three environmental studies have been reported in the literature with levels ranging from ND to
66 nmol/L. The number of positive results in all three studies was low (<1.5% of total samples analyzed).
When compared with our results (ND – 237 nmol/L), the studies suggest general population exposures
are within the ADI. However, the very short half-life makes determining intermittent environmental
exposures difﬁcult.
Crown Copyright ã 2014 Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Methamidophos is an organophosphate pesticide, used widely
in agriculture for the protection of a wide range of crops. It is also a
metabolite of acephate, another widely used organophosphate
pesticide. As organophosphate (OP) pesticides have been reported
as the most commonly used insecticides in agriculture (Jaga and
Dharmani, 2004; Kamanyire and Karalliedde, 2004) it is difﬁcult to* Corresponding author. Tel.: +44 1298 218435.
E-mail address: kate.jones@hsl.gsi.gov.uk (K. Jones).
http://dx.doi.org/10.1016/j.toxlet.2014.10.008
0378-4274/Crown Copyright ã 2014 Published by Elsevier Ireland Ltd. This is an open acce
nc-nd/3.0/).completely avoid exposure. Methamidophos is toxic via all routes
of exposure and is a cholinesterase inhibitor, capable of over
stimulating the central nervous system causing dizziness, confu-
sion, and ultimately death at very high exposures (Christiansen
et al., 2011; Mason, 2000). Consequently, it is important to control
exposure. An acceptable daily intake (ADI) of 0.004 mg/kg of body
weight per day has been established for methamidophos (JMPR,
2002).
Biological monitoring is a useful approach for determining
systemic exposure to chemicals by all routes; it enables the
quantiﬁcation of a compound, or its metabolites, in non-invasive
samples such as urine. This approach is suitable for monitoringss article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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determination of the actual absorbed amount of chemical in an
individual. However, such an approach requires both a suitable
analytical method and an appropriate reference range in order to
interpret the data.
Once exposure occurs OP insecticides are usually metabolized
via hydrolysis and the alkylphosphate or speciﬁc metabolite
residue is analyzed (Montesano et al., 2007), but with methami-
dophos the intact parent pesticide can be measured, with several
methods having been reported (Montesano et al., 2007; Olsson
et al., 2003; Jayatilaka et al., 2010; Savieva et al., 2004).
There have been no published studies in the open literature
describing human volunteer exposure to methamidophos. The
Joint FAO/WHO Meeting on Pesticide Residues (JMPR, 2002)
describes two unpublished reports – one looking at cholinesterase
activity from multiple oral dosing (no urine sampling reported)
and one looked at dermal exposure using radiolabelled meth-
amidophos. The present study has quantiﬁed methamidophos
excretion in timed urinary collections from six volunteers who
received a single oral dose at the ADI. Data from three other studies
is included (Montesano et al., 2007; Olsson et al., 2003; Centers for
Disease Control and Prevention, National Biomonitoring Pro-
gramme, 2013) for comparison of methamidophos levels in general
population against that of urine levels after ADI exposure.
2. Methods
2.1. Chemicals
Certiﬁed methamidophos was purchased from QMX Laborato-
ries (Thaxted, UK) and internal standard d6-methamidophos
(100 mg/L) from Dr. Ehrenstorfer (Augsburg, Germany). All
solvents and reagents used were of analytical grade.
2.2. Volunteer study
The protocol used in this study was approved by the HSE
Research Ethics Committee (ETHCOM/REG/06/03). After giving
informed written consent, six volunteers were given a single oral
dose (based on body weight) of methamidophos at the ADI
(0.004 mg/kg) dissolved in ethanol and diluted with a soft drink.
Volunteer details are shown in Table 1. Total urine excreted was
collected at timed intervals up to 24 h post-exposure. The volume
of each sample was recorded and an aliquot retained for analysis
(<15 C). Samples were also analyzed for creatinine concentra-
tion to account for dilution. Samples for ﬁve of the six volunteers
were stored frozen for ﬁve years prior to analysis.
2.2.1. Sample preparation
We investigated previously reported methods (Montesano
et al., 2007; Olsson et al., 2003; Jayatilaka et al., 2011; Savieva
et al., 2004) and found problems with recovery when freeze drying.
Liquid/liquid extraction also gave some problems, but these were
overcome with the use of a higher volume of solvent (10 mL). This
was found to give fewer interferences in the chromatography and
increased sensitivity, enabling a detection limit of 7 nmol/L,Table 1
Details of the volunteers.
Code Sex Age Height (m) Weight (kg) BMI
A F 35 1.715 77 26.2
B M 55 1.71 94 32.1
C F 23 1.75 107 34.9
D M 26 1.76 102 32.9
E M 54 1.895 96 26.7
F F 41 1.75 78 25.5although this is higher than reported for some other methods
(Montesano et al., 2007 – 1.1 nmol/L; Centers for Disease Control
and Prevention, National Biomonitoring Programme, 2013 –
0.7 and 2.6 nmol/L).
All samples were analyzed in duplicate. Aliquots of urine
(10 mL) were added to a sterilin tube and spiked with 50 mL
internal standard (d6-methamidophos, 1 mg/L). Calibration stand-
ards (0–282 nmol/L were prepared in urine and quality control
samples (prepared by spiking urine with methamidophos at a
concentration of 70 nmol/L) were also analyzed throughout the
analytical run. Liquid/liquid extraction was carried out by adding
10 mL of dichloromethane to all tubes and rolling for 20 min. The
samples were then centrifuged and the solvent layer was removed
and evaporated to dryness under nitrogen. Samples were
reconstituted in 50 mL methanol and transferred to vials for
analysis.
2.2.2. Sample analysis
LC–MS/MS analysis was performed on a Shimadzu SPD-M20A
HPLC coupled to a 3200 Q-Trap AB Sciex tandem mass
spectrometer with compounds optimised in positive ion electro-
spray MRM (Tables 2 and 3). An isocratic HPLC method (70% A:30%
B) was set up using a ZORBAX SB-C3 Agilent column (4.6  150 mm
– 5 mm), with mobile phase A (0.1% formic acid in water) and B
(0.1% formic acid in methanol) run at a total ﬂow rate of 0.2 mL/min
with an overall run time of 15 min. The injection volume was 2 mL.
Selected transitions monitored were m/z 142/94 (methamidophos)
and 148/97 (d6-methamidophos), see Table 2.
2.2.3. Method characteristics
The assay was linear up to at least 282 nmol/L (least squares
regression coefﬁcient of >0.99). Analysis of quality control samples
gave an inter-assay variation of 4% (N = 5, at a concentration of
70 nmol/L). The method had a detection limit of 7 nmol/L (three
times signal:noise ratio).
2.2.4. Creatinine analysis
Creatinine was determined in all urine samples by an
automated alkaline picrate method (Jaffé reaction) using a Pentra
400 (ABX, France) (Cocker et al., 2011). The coefﬁcient of variation
for within-day analysis was 1.5% and for between-day analysis was
3% at 6 mmol/L.
3. Results
Example chromatograms for a calibration standard, blank urine,
and positive urine after dosing are shown in Fig. 1. Fig. 2 shows the
time course of urinary excretion of methamidophos (normalised
for a 70 kg volunteer). Elimination was rapid, with the majority of
the recovered dose (range 0.04–1.71%) being excreted within 8 h of
dosing, and a mean half-life of 1.1 h (range 0.4–1.5 h, Fig. 3). Peak
urinary concentrations were found at 2 h post-dose (except for
volunteer C, 6 h post-dose). Table 4 shows individual concen-
trations of methamidophos in each volunteer sample, up to 24 h
after dosing (not normalised), and the total percentage of dose
recovered for each volunteer.
Mean methamidophos levels found in the 24 h total urine
collections (normalised for a 70 kg volunteer) were found to be
9.2 nmol/L (range 1.0–19.1). One volunteer excreted exceptionally
low levels of methamidophos following dosing (volunteer C);
excluding this result the range was 6.7–19.1 nmol/L, with a mean of
10.9 nmol/L.
There was little difference in inter-individual variability,
whether creatinine correction was used or not. As a consequence
(and as other researchers have not used creatinine correction), all
results are discussed here without creatinine correction.
Table 2
Optimised LC–MS parameters.
Transition Declustering potential (V) Entrance potential (V) Cell exit potential (V) Collision energy
Methamidophos 142/94 46 10 4 21
d6-Methamidophos 148/97 46 10 4 21
Table 3
Source/gas parameters.
Curtain gas (psi) 25
Collision cell gas (psi) Medium
Ion spray voltage (V) 5500
Temperature (C) 400
Source gas 1 (psi) 40
Source gas 2 (psi) 40
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Since this study was conducted methamidophos has been
banned in Europe and the U.S (The Pesticide Manual, 2012; US EPA,
2009), and is being phased out of use. It is still used throughout the
rest of the world, e.g., South Africa (Quinn et al., 2011). The present
study has quantiﬁed urinary metabolite levels in volunteersFig.1. Example chromatograms – top:- 528 nmol/L standard in urine, response of 10,00
sample containing 54 nmol/L, 2 h after dosing, response 1200.exposed to a single oral dose at the ADI (0.004 mg/kg). Our data
shows that methamidophos is rapidly excreted in urine (mean
half-life 1.1 h) compared to some other organophosphate pesti-
cides such as chlorpyrifos-methyl, which has a half-life of 16 h
(Sams and Jones, 2011). However, it does has similar characteristics
of other organophosphate pesticides investigated by this labora-
tory, such as diazinon with a half-life of 2 h (Garﬁtt et al., 2002).
The dose recovery of methamidophos was low in our study with
a mean recovery of only 1.1% (range 0.04–1.71%) of the dose being
excreted as methamidophos in urine. One report that has been
published (Salama et al., 1992) compares well with our ﬁndings
and shows that methamidophos undergoes extensive metabolism
in rats, only 23% of the methamidophos dose was excreted in urine,
and only a small percentage of this was actually excreted as
unchanged methamidophos. Another, study in rats (Fakhr et al.,
1982) found only 1.4% of the methamidophos was recovered
unchanged in urine. This suggests that low dose recovery may be0. Middle:- blank urine (contains internal standard only). Bottom:- volunteer A urine
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Fig. 2. Mean (standard deviation, n = 6) excretion of methamidophos (nmol) in
urine after an oral dose at the ADI (0.004 mg/kg), normalised to a 70 kg volunteer.
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Fig. 3. Example excretion curve (volunteer B) showing a half-life of 1.4 h (r = 0.96,
least squares regression).
Table 4
Showing concentration (nmol/L) of methamidophos in volunteer urine samples up to 2
Concentration in nmol/L
Volunteer
A B 
Pre sample 0 0 
2 h after dose 54 218 
4 h after dose 31 92 
6 h after dose 17 24 
8 h after dose 9 21 
12 h after dose 0 0 
20 h after dose 0 0 
24 h after dose 0 0 
Total % of dose recovered 0.82 1.71 
Table 5
Comparison data with other studies (nmol/L).
Study LoD Geometric mean Range 
Montesano et al. (2007) 1.1 13.9 <LoD-66 
Olsen et al. (2003) 5.6 10.56 <LoD-16.3
This study (2014) 7 – <LoD-237
CDC (2013) 0.7a – All <LoD 
2.6b – All <LoD 
LoD – Limit of detection.
a 2003/2004 survey.
b 2005/2006 survey.
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dose recovery results in urine may be obtained by measuring
methamidophos metabolites such as O,S-dimethyl hydrogen
phosphorothioate (Tomaszewska and Hebert, 2003). This would
require further investigation. However, methamidophos was
chosen as the biomarker in this study to reﬂect the risk of
exposure to methamidophos, rather than a detoxiﬁcation metab-
olite. Diet is likely to be a source of exposure to the general
population and it has been shown that metabolites can be present
as residues, therefore measuring methamidophos itself better
reﬂects the risk from food.
One of our volunteers showed exceptionally low excretion of
methamidophos following dosing; this may be due to differences
in metabolism but this has not been investigated further.
Alternatively, methamidophos may be hydrolyzed to its metab-
olites in the acidity of the stomach and then absorbed into the
body, although available data suggests that methamidophos is
stable under acidic conditions (IPCS, 2014).
Due to research priorities, samples for ﬁve of the six volunteers
were stored frozen for ﬁve years prior to analysis. In order to check
stability, samples from a further volunteer were collected prior to
analysis. Volunteers A–E (except C) showed comparable excretion
to volunteer F (analyzed immediately after collection) indicating
that the earlier samples were stable. This supports data from
Montesano et al. (2007) showing methamidophos stability at
20 C. It is therefore unlikely that the results from the anomalous
volunteer C are due to degradation.
With such rapid elimination it would be appropriate to collect
samples soon after exposure or at the end of each shift for
occupational studies. For environmental studies, the short half-life
means that estimates of exposure using biomonitoring are likely to
be highly variable (Aylward et al., 2012). Signiﬁcant inter-
individual variability in excretion is also likely, judging by
volunteer C in our cohort. Three environmental studies have been
reported in the literature (Table 5). The number of positive samples
in all three of the studies was low (<1.5% in all three studies),
probably reﬂecting the rapid excretion and intermittent exposures4 h after dosing (not normalised), and total percentage of dose recovered.
C D E F
6 0 0 0
19 237 59 88
12 28 45 53
22 0 38 9
0 0 10 0
0 0 0 0
0 0 0 0
0 0 0 0
0.04 1.20 1.28 1.62
%> LoD Details
1.3 499 General population (California, USA)
 [over 24 h] 1.4 140 General population(2 sites, USA)
 – 6 Volunteers at the ADI
0 1401 Adults(across USA)
0 1535 Adults(across USA)
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(particularly taking into account the extent of negative results in
the environmental surveys) it shows that general population
exposure in countries where methamidophos is still in use is likely
to be well within the ADI.
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